Important Notice Regarding Inveltys

Posted in Latest News on February 11, 2019.

During the February 8, 2019 Board of Optometry meeting, the board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002, F.A.C. Formulary of Topical Ocular Pharmaceutical Agents.

Important note: At this time, Inveltys cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and Inveltys may be prescribed by certified optometrists at that time.



More Latest News

New Legislation Impacting Your Profession
June 29, 2021

Click here to view a full list of bill summaries from the 2021 Florida Legislative Session that may impact your profession. Continue reading


Third Quarter Performance Report
June 9, 2021

Released for the
2020-21 Fiscal Year Continue reading